Home/Database/Lanreotide
Growth HormoneClinical

Lanreotide

Lanreotide acetate

8 Amino Acids · MW: 1096.3 Da

Amino Acids

8

Molecular Weight

1096.3 Da

Half-life

7-10 days (depot)

Research Score

4.8

Studies

3000

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is Lanreotide?

Long-acting somatostatin analog with high affinity for receptors involved in GH suppression. It is used in clinical and translational studies for acromegaly and hormone-secreting tumors.

Key Benefits & Mechanisms

GH suppression

IGF-1 lowering

acromegaly control

neuroendocrine tumor control

Research Summary

Lanreotide provides sustained somatostatin receptor activation and is a major long-acting comparator in GH-axis therapy research. Its depot formulations make it a standard tool for evaluating long-duration endocrine suppression.